• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Idenix Pharmaceuticals

Idenix Pharmaceuticals

  1. SEC announces insider trading charges for N.J. man for pharmaceutical acquisition knowledge

    SEC announces insider trading charges for N.J. man for pharmaceutical acquisition knowledge

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.